Most Read Articles
Saras Ramiya, one year ago
According to a meta-analysis of 22 randomized controlled trials, corticosteroids alone or in combination with pentoxifylline or N-acetylcysteine improve 28-day survival among patients with severe alcoholic hepatitis.
Jackey Suen, one year ago
Researchers from the Chinese University of Hong Kong (CUHK) have identified a seven-microRNA (miRNA) signature, which may be used to predict survival in patients with hepatocellular carcinoma (HCC). [PLos ONE 2015, doi:10.1371/journal.pone.0128628]
one year ago
Adjunct boceprevir is  effective for patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-genotype-1 coinfection unresponsive to pegylated interferon/ribavarin (PEGIFN/RBV) therapy, as shown in a retrospective study.
Jackey Suen, 2 years ago
Over one-third of patients with prior hepatitis B virus (HBV) exposure had HBV reactivation 2 years after haematopoietic stem cell transplantation (HSCT), according to a study by The University of Hong Kong (HKU). 

The Role of SAMe in the Treatment of Liver Diseases

one year ago
At a recent Abbott-sponsored symposium during the 11th Liver Update 2015, Professor José Mato discussed the role of S-adenosylmethionine (SAMe) in liver diseases. The following are highlights from his talk.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Saras Ramiya, one year ago
According to a meta-analysis of 22 randomized controlled trials, corticosteroids alone or in combination with pentoxifylline or N-acetylcysteine improve 28-day survival among patients with severe alcoholic hepatitis.
Jackey Suen, one year ago
Researchers from the Chinese University of Hong Kong (CUHK) have identified a seven-microRNA (miRNA) signature, which may be used to predict survival in patients with hepatocellular carcinoma (HCC). [PLos ONE 2015, doi:10.1371/journal.pone.0128628]
one year ago
Adjunct boceprevir is  effective for patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-genotype-1 coinfection unresponsive to pegylated interferon/ribavarin (PEGIFN/RBV) therapy, as shown in a retrospective study.
Jackey Suen, 2 years ago
Over one-third of patients with prior hepatitis B virus (HBV) exposure had HBV reactivation 2 years after haematopoietic stem cell transplantation (HSCT), according to a study by The University of Hong Kong (HKU).